Inirekomenda ni infectious disease expert Dr. Rontgene Solante sa gobyerno na napapanahon na para rebisahin muli ang datos kaugnay sa dengue vaccine na Dengvaxia.
“Dito sa Pilipinas, where the dengue is really very high, tayo po ‘yung walang ganitong klaseng preventive measures,” ayon kay Solante sa ginanap na Laging Handa briefing.
Ang Dengvaxia ay may lisensiya sa ilang bansa gaya ng Singapore, Thailand, Indonesia at Malaysia.
“I think it’s high time that, if in case the government should consider having the Dengvaxia, they should review the data, they should review the beenefit of this vaccine which is prevention of hospitalization and prevention of severe dengue,” dagdag ni Solante.
Si Solante, na siya ring vice president ng Philippine College of Physicians,ay nagpahayag na mahalaga na.mayroong age group sa pagbibigay ng dengue vaccine para hindi ito tanggihan ng publiko.
“The vaccine is still suspended. The suspension should be lifted before we can use it. Now, kung puwede na natin gamitin, there should be guidelines on kailan natin siya gamitin, at sinong population na puwede nating gamitin,” dagdag ni Solante. (Arsenio Tan)
